top of page

Peer-Reviewed Articles in Chung-Ang U. (2024.03.01-Current)       

47. Paul A. Archer, Samuel Lucas, Jihoon Kim* (Co-corresponding author), Susan N. Thomas*, In preparation.

46. Soo-Hyang Chi†, Do-Kyun Kim†, Sang-Hun Choi, Young-Eun Cho*, Jihoon Kim* (Co-corresponding author), In preparation.

45. Sang-Hun Choi, Soo-Hyang Chi, Yu-Seong Park, Sejin Son, Young-Eun Cho*, Jihoon Kim* (Co-corresponding author), In submission.

Peer-Reviewed Articles in Yonsei U. (2022.09.01-2024.02.29)

44. Sang-Hun Choi†, Jung-Young Eom†, Hyun-Jin Kim, Wonhyo Seo, Hyo-Jung Kwon, Do-Kyun Kim, Jihoon Kim* (Co-corresponding author), Young-Eun Cho*, Aloe-derived Nanovesicles Attenuate Inflammation and Enhance Tight Junction Proteins for Acute Colitis Treatment. Biomaterials Science, 2023, 11, 5490-5501. (2021 IF=7.590, Q1 18.89%, 2022 IF=6.600, Q2 25.6%) – 2023.08.08 (Online: 2023.6.21)

43. Jihoon Kim (1st author), Paul A. Archer, Margaret P. Manspeaker, Alexa R. C. Avecilla, Brian P. Pollack, Susan N. Thomas*, Sustained Release Hydrogel for Durable Locoregional Chemoimmunotherapy for BRAF-Mutated Melanoma. Journal of Controlled Release, 2023, 357, 655-668. (2021 IF=11.467 Q1 4.12%, 2022 IF=10.8 Q1 4.2%) – 2023.05.01 (Online: 2023.04.27).

-Highlighted in BRIC.org

42. Jin-Hyeon Hwang†, Yu-Seong Park†, Hyuk Soon Kim†, Dong-ha Kim, Sang-Hoon Lee, Chan-Hyeong Lee, Seung-Hoon Lee, Jung-Eun Kim, Sangkyu Lee, Ho Min Kim, Hyun‑Woo Kim, Jihoon Kim, Wonhyo Seo, Hyo-Jung Kwon, Byoung-Joon Song, Do-Kyun Kim*, Moon-Chang Baek*, and Young-Eun Cho*, Yam-derived exosome-like nanovesicles stimulate osteoblast formation and prevent osteoporosis in mice. Journal of Controlled Release, 2023, 355, 184-198. (2021 IF=11.467 Q1 4.12%, 2022 IF=10.8 Q1 4.2%) – 2023.03.01 (Online: 2023.02.06).

-Highlighted in BRIC.org

41. Kyeong Jin Cho, Young-Eun Cho, Jihoon Kim* (Corresponding author)Locoregional Lymphatic Delivery Systems Using Nanoparticles and Hydrogels for Anticancer Immunotherapy. Pharmaceutics, 2022, 14, 2752. (2021 IF=6.525 Q1 13.8%, 2022 IF=5.4 Q1 18.2%) – 2022.12.08 (Online: 2022.12.08)

40. Jihoon Kim (1st author), Susan N. Thomas*, Opportunities for Nitric Oxide in Potentiating Cancer Immunotherapy. Pharmacological Reviews, 2022, 74, 1146-1175. (2021 IF=20.479 Q1 0.9%, 2022 IF=21.1 Q1 0.9%) – 2022.10.01 (Online: 2022.10.01)

-Highlighted in BRIC.org

-Representative Review Article 1

Peer-Reviewed Articles Before Tenure-Track (~2022.08.31)

39. Taejeong Kim, Hyun Jin Kim, Wonseok Choi, Yeong Mi Lee, Jung Hyun Pyo, Junseok Lee, Jeesu Kim, Jihoon Kim, Joung-Hun Kim, Chulhong Kim, Won Jong Kim*, Deep brain stimulation by blood–brain-barrier-crossing piezoelectric nanoparticles generating current and nitric oxide under focused ultrasound. Nature Biomedical Engineering, 2022, https://doi.org/10.1038/s41551-022-00965-4. (2021 IF=29.234 Q1 0.51%, 2022 IF=28.1 Q1 0.5%) – 2022.12.01 (Online: 2022.12.01)

-Highlighted in BRIC.org

38. Hyun-Jin Kim†, Jung-Young Eom†, Sang-Hun Choi†, Hyun-Ju Seo, In-Sook Kwun, Ik-Jo Chun, Jeehye Sung, Jae-Hwan Lim, Jihoon Kim, Byoung-Joon Song, Chan-Hyeong Lee, Do-Kyun Kim, Moon-Chang Baek*, Young-Eun Cho*, Plum prevents intestinal and hepatic inflammation in the acute and chronic models of dextran sodium sulfate-induced mouse colitis. Molecular Nutrition and Food Research, 2022, 66, 2101049 (2020 IF=5.820 Q1 5.21%, 2022 IF=5.2 Q1 23.6%). – 2022.07.01 (Online: 2022.04.27)

 

37. Jihoon Kim (1st author), David M. Francis, Lauren F. Sestito, Paul A. Archer, Margaret P. Manspeaker, Meghan O'Melia, Susan N. Thomas*, Thermosensitive hydrogel releasing nitric oxide donor and anti-CTLA-4 micelles for anti-tumor immunotherapy. Nature Communications, 2022, 13, 1479. (2020 IF=14.919 Q1 4.86%, 2022 IF=16.6 Q1 7.5%) – 2022.03.18 (Online: 2022.03.18)

-Highlighted in BRIC.org

 -Representative Research Article 1

36. Taejeong Kim†, Jeeyeon Suh†, Jihoon Kim* (Co-corresponding author), Won Jong Kim*, Lymph-Directed Self-Immolative Nitric Oxide Prodrug for Inhibition of Intractable Metastatic CancerAdvanced Science, 2022, 9, 2101935. (2020 IF=16.806 Q1 5.24%, 2022 IF=15.1 Q1 6.9%) – 2022.03.15 (Online: 2022.01.05)

-Inside Back Cover

-Highlighted in BRIC.org

 -Representative Research Article 3 

35. Meghan J. O’Melia, Adriana Mulero-Russe, Jihoon Kim, Alyssa Pybus, Deborah DeRyckere, Levi Wood, Douglas K. Graham, Edward Botchwey, Andrés J. García, Susan N. Thomas*, Synthetic matrix scaffolds engineer the in vivo tumor immune microenvironment for immunotherapy screening. Advanced Materials, 2022, 34, 2108084. (2020 IF=30.849 Q1 2.16%, 2022 IF=29.4 Q1 2.2%)– 2022.03.10 (Online: 2022.01.06)

 

34. Dong-Ha Kim, Yejin Sim, Jin-Hyeon Hwang, In-Sook Kwun, Jae-Hwan Lim, Jihoon Kim, Jee-In Kim, Moon-Chang Baek, Mohammed Akbar, Wonhyo Seo, Do-Kyun Kim, Byoung-Joon Song *, Young-Eun Cho *, Ellagic Acid Prevents Binge Alcohol-Induced Leaky Gut and Liver Injury through Inhibiting Gut Dysbiosis and Oxidative stress. Antioxidants, 2021, 10, 1386. (2020 IF=6.313 Q1 7.34%, 2022 IF=7.0 Q1 8.8%) – 2021.08.30 (Online: 2021.08.30)

 

33. Jihoon Kim (1st author), Paul A. Archer, Susan N. Thomas*, Innovations in Lymph Node Targeting NanocarriersSeminars in Immunology, 2021, 56, 101534. (2020 IF=11.130 Q1 8.33%, 2022 IF=7.8 Q1 19.6%). – 2021.08.01 (Online: 2021.11.24)

-Highlighted in BRIC.org

 -Representative Review Article 2

32. Jihoon Kim* (1st author&Co-corresponding author), Jee Seon Kim, Kyung Hyun Min, Young-Hwa Kim, Xiaoyuan Chen*, Bombesin-Tethered Reactive Oxygen Species (ROS)-Responsive Nanoparticles for Monomethyl Auristatin F (MMAF) Delivery. Bioengineering, 2021, 8,43. (2019 IF=None, 2022 IF=4.6 Q2 34.9%) – 2021.03.29 (Online: 2021.03.29)

 

31. Jihoon Kim (1st author), David M. Francis, Susan N. Thomas*, In Situ Crosslinked Hydrogel Depot for Sustained Antibody Release Improves Immune Checkpoint Blockade Cancer Immunotherapy. Nanomaterials, 2021, 11, 471. (2019 IF=4.324 Q2 33.24%, 2022 IF=5.3 Q1 23.6%) – 2021.02.12 (online: 2021.02.12)

 

30. Jihoon Kim (1st author), Lauren F. Sestito, Sooseok Im, Won Jong Kim, Susan N. Thomas*, Poly(cyclodextrin)-Polydrug Nanocomplexes as Synthetic Oncolytic Virus for Locoregional Melanoma ChemoimmunotherapyAdvanced Functional Materials, 2020, 30, 1908788. (2018 IF=15.621 Q1 3.04%, 2022 IF=19.0 Q1 4.2%) – 2020.04.20 (Online: 2020.02.24)

-Highlighted in BRIC.org

  -Representative Research Article 2

29. Dongsik Park, Sooseok Im, Gurusamy Saravanakumar, Yeong Mi Lee, Jinhwan Kim, Kunho Kim, Junseok Lee, Jihoon Kim* (Co-corresponding author), Won Jong Kim*, A Cyotosol-Selective Nitric Oxide Bomb as a New Paradigm of Anticancer DrugChemical Communications, 2019, 55, 14789-14792. (2018 IF=6.164 Q1 18.31%, 2022 IF=4.9 Q2 33.4%) – 2019.12.21 (Online: 2019.11.14)

 

28. Jiwon Yeo, Yeong Mi Lee, Junseok Lee, Dongsik Park, Kunho Kim, Jihoon Kim, Junghong Park, Won Jong Kim*, Nitric Oxide-Scavenging Nanogel for Treating Rheumatoid ArthritisNano Letters, 2019, 19, 6716-6724. (2017 IF=12.080 Q1 5.84%, 2022 IF=10.8 Q1 7.67%) – 2019.10.09 (Online: 2019.05.13)

-Highlighted in BRIC.org

 

27. Jihoon Kim (1st author), Margaret P. Manspeaker, Susan N. Thomas*, Augmenting the Synergies of Chemotherapy and Immunotherapy through Drug DeliveryActa Biomaterialia, 2019, 88, 1-14. (2017 IF=6.383 Q1 4.49%, 2022 IF=9.7 Q1 8.9%) – 2019.04.01 (Online: 2019.02.12)

 

26. Swapan Pramanick†, Jihoon Kim† (Co-1st author), Jinhwan Kim, Gurusamy Saravanakumar, Dongsik Park, Won Jong Kim*, Synthesis and Characterization of Nitric Oxide-Releasing Platinum (IV) Prodrug and Polymeric Micelle Triggered by LightBioconjugate Chemistry, 2018, 29, 885-897. (2016 IF=4.818 Q1 12.18%, 2022 IF=4.7 Q1 14.4%) – 2018.04.18 (Online: 2017.12.27) 

 

25. Jihoon Kim (1st author), Bryant C. Yung, Won Jong Kim*, Xiaoyuan Chen*, Combination of Nitric Oxide and Drug Delivery Systems: Tools for Overcoming Drug Resistance in ChemotherapyJournal of Controlled Release, 2017, 263, 223-230. (2016 IF=7.786 Q1 3.7%, 2022 IF=10.8 Q1 4.2%) – 2017.10.10 (Online: 2016.12.26)

 

24. Padmanaban Guruprasath, Jihoon Kim, Gowri Rangaswamy Gunassekaran, Lianhua Chi, Soyoun Kim, Rang-Woon Park, Sang-Hyun Kim, Moon-Chang Baek, Sang Mun Bae, Sang-Yeob Kim, Dong-Kyu Kim, In-Kyu Park, Won-Jong Kim*, Byungheon Lee*, Interleukin-4 Receptor-Targeted Bcl-xL siRNA Enhances Sensitivity to Chemotherapy and Inhibits Tumor GrowthBiomaterials, 2017, 142, 101-111. (2016 IF=8.402 Q1 1.52%, 2022 IF=14.0 Q1 3.3%) – 2017.10.01 (Online: 2017.07.15)

 

23. Kyunghyun Min, Young-Hwa Kim, Zhantong Wang, Jihoon Kim, Jee Seon Kim, Sun Hwa Kim, Kwangmyeong Kim, Ick Chan Kwon, Dale Kiesewetter, Xiaoyuan Chen*, Engineered Zn(II)-Dipicolyamine-Gold Nanorod Provides Effective Prostate Cancer Treatment by Combining siRNA Delivery and Photothermal TherapyTheranostics, 2017, 7, 4240-4254. (2016 IF=8.712 Q1 5.86%, 2022 IF=12.4 Q1 5.5%) – 2017.09.26 (Online: 2017.09.26)

 

22. Xingshu Li†, Jihoon Kim† (Co-1st author), Juyoung Yoon*, Xiaoyuan Chen*, Cancer-Associated, Stimuli-Driven, Turn On Theranostics for Multimodality Imaging and TherapyAdvanced Materials, 2017, 29, 1606857. (2015 IF=18.960 Q1 1.04%, 2022 IF=29.4 Q1 2.2%) – 2017.06.20 (Online: 2017.03.29) 

-Highlighted in BRIC.org

 -Representative Review Article 4

21. Young-Hwa Kim†, Kyung Hyun Min†, Zhantong Wang, Jihoon Kim, Orit Jacobson, Peng Huang, Guizhi Zhu, Yijing Liu, Bryant Yung, Gang Niu*, Xiaoyuan Chen*, Development of Sialic Acid-Coated Nanoparticles for Targeting Cancer and Efficient Evasion of the Immune SystemTheranostics, 2017, 7, 962-973. (2015 IF=8.854 Q1 6.85%, 2022 IF=12.4 Q1 5.5%) – 2017.02.23 (Online: 2017.02.23)

 

20. Gurusamy Saravanakumar†, Jihoon Kim† (Co-1st author), Won Jong Kim*, Reactive-Oxygen-Species (ROS)-Responsive Drug Delivery Systems: Promises and ChallengesAdvanced Science, 2017, 4, 1600124. (2015 IF=6.0 Q1 10.52, 2022 IF=15.1 Q1 6.9%) – 2017.01.01 (Online: 2016.06.08) 

-Highlighted in BRIC.org

 -Representative Review Article 3

19. Dongsik Park, Jihoon Kim, Yeong Mi Lee, Junghong Park, Won Jong Kim*, Polydopamine Hollow Nanoparticle Functionalized with N-Diazeniumdiolates as a Nitric Oxide Delivery Carrier for Antibacterial TherapyAdvanced Healthcare Materials, 2016, 5, 2019–2024. (2015 IF=5.760 Q1 4.61%, 2022 IF=10.0 Q1 7.8%) – 2016.08.24 (Online: 2016.06.22) 

 

18. Hyeonjeong Jeon†, Jihoon Kim† (Co-1st author), Yeong Mi Lee, Jinhwan Kim, Hyung Woo Choi, Junseok Lee, Hyeongmok Park, Youngnam Kang, In-San Kim, Byung-Heon Lee, Allan S. Hoffman, Won Jong Kim*, Poly-Paclitaxel/Cyclodextrin-SPION Nano-Assembly for Magnetically Guided Drug Delivery SystemJournal of Controlled Release, 2016, 231, 68-76. (2014 IF=7.705 Q1 3.74%, 2022 IF=10.8 Q1 4.2%) – 2016.06.10 (Online: 2016.01.09)

 

17. Hyung Woo Choi†, Jihoon Kim† (Co-1st author), Jinhwan Kim, Yonghwi Kim, Hyun Beom Song, Jeong Hun Kim, Kimoon Kim, Won Jong Kim*, Light-Induced Acid Generation on Gatekeeper for Smart Nitric Oxide DeliveryACS Nano, 2016, 10, 4199-4208. (2014 IF=12.881 Q1 3.65%, 2022 IF=17.1 Q1 5.7%) – 2016.04.26 (Online: 2016.03.08)

-Highlighted in BRIC.org

  -Representative Research Article 5

16. Jinhwan Kim†, Jihoon Kim† (Co-1st author), Cherlhyun Jeong*, Won Jong Kim*, Synergistic Nanomedicine by Combined Gene and Photothermal TherapyAdvanced Drug Delivery Review, 2016, 98, 99-112. (2014 IF=15.038 Q1 1.37, 2022 IF=16.1 Q1 1.3%) – 2016.03.01 (Online: 2015.12.31)

-Highlighted in BRIC.org

 -Representative Review Article 5

15. Jinhwan Kim, Yeong Mi Lee, Hyunwoo Kim, Dongsik Park, Jihoon Kim, Won Jong Kim*, Phenylboronic Acid-Sugar Grafted Polymer Architecture as a Dual Stimuli-Responsive Gene Carrier for Targeted Anti-Angiogenic Tumor TherapyBiomaterials, 2016, 75, 102-111. (2014 IF=8.557 Q1 1.52%, 2022 IF=14 Q1 3.3%) – 2016.01.01 (Online: 2015.10.14)

 

14. Youngnam Kang, Jihoon Kim, Yeong Mi Lee, Sooseok Im, Hansoo Park*, Won Jong Kim*, Nitric Oxide-Releasing Polymer Incorporated Ointment for Cutaneous Wound HealingJournal of Controlled Release, 2015, 220, 624-630. (2014 IF=7.705 Q1 3.74%, 2022 IF=10.8 Q1 4.2%) – 2015.12.28 (Online: 2015.09.05)

 

13. Jihoon Kim† (Co-1st author), Swapan Pramanick†, Duhwan Lee, Hansoo Park*, Won Jong Kim*, Polymeric Biomaterials for the Delivery of Platinum-Based Anticancer DrugsBiomaterials Science, 2015, 3, 1002-1017. (2014 IF=3.831 Q2 28.79%, 2022 IF=6.600 Q2 25.6%) – 2015.07.01 (Online: 2015.04.20)

 

12. Duhwan Lee†, Yeong Mi Lee†, Jihoon Kim, Myung Kyu Lee, Won Jong Kim*, Enhanced Tumor-Targeted Gene Delivery by Bioreducible Polyethylenimine Tethering EGFR Divalent LigandsBiomaterials Science, 2015, 3, 1096-1104. (2014 IF=3.831 Q2 28.79%, 2022 IF=6.600 Q2 25.6%) – 2015.07.01 (Online: 2015.02.17)

 

11. Gurusamy Saravanakumar, Junseok Lee, Jihoon Kim, Won Jong Kim*, Visible Light-Induced Singlet Oxygen-Mediated Intracellular Disassembly of Polymeric Micelles Co-Loaded with Photosensitizer and Anticancer Drug for Enhanced Photodynamic TherapyChemical Communications, 2015, 51, 9995-9998. (2013 IF=6.065 Q1 13.18%, 2022 IF=4.9 Q2 33.4%) – 2015.06.21 (Online: 2015.05.12)

 

10. Yeong Mi Lee†, Duhwan Lee†, Jihoon Kim, Hansoo Park*, Won Jong Kim*, RPM Peptide Conjugated Bioreducible Polyethylenimine Targeting Invasive Colon CancerJournal of Controlled Release, 2015, 205, 172-180. (2013 IF=6.718 Q1 4.1%, 2022 IF=10.8 Q1 4.2%) – 2015.05.10 (Online: 2015.01.21)

 

9. Ran Namgung, Yeong Mi Lee, Jihoon Kim, Yuna Jang, Byung-Heon Lee, In-San Kim, Pandian Sokkar, Young Min Rhee, Allan S. Hoffman, Won Jong Kim*, Poly-Cyclodextrin and Poly-Paclitaxel Nano-Assembly for Anticancer TherapyNature Communications, 2014, 5, DOI: 10.1038/ncomms4702 (Article number: 3702). (2012 IF=10.015 Q1 4.46%, 2022 IF=16.6 Q1 7.5%) – 2014.05.08 (Online: 2014.05.08)

-Highlighted in BRIC.org

 

8. Jihoon Kim (1st author), Gurusamy Saravanakumar, Hyung Woo Choi, Dongsik Park, Won Jong Kim*, A Platform for Nitric Oxide DeliveryJournal of Materials Chemistry B, 2014, 2, 341-356. (2012 IF=6.108 Q1 8.09%, 2022 IF=7.0 Q1 21.1%) – 2014.01.28 (Online: 2013.10.29)

 

7. Junghong Park, Jihoon Kim, Kaushik Singha, Dong-Keun Han, Hansoo Park*, Won Jong Kim*, Nitric Oxide Integrated Polyethylenimine-Based Tri-Block Copolymer for Efficient Antibacterial ActivityBiomaterials, 2013, 34, 8766-8775. (2012 IF=7.604 Q1 1.85%, 2022 IF=14.0 Q1 3.3%) – 2013.11.01 (Online: 2013.08.06)

 

6. Seonki Hong†, Jihoon Kim† (Co-1st author), Yun Suk Na, Junghong Park, Sunjin Kim, Kaushik Singha, Gun-il Im, Dong-Geun Han, Won Jong Kim*, Haeshin Lee*, Poly(norepinephrine): Ultrasmooth Material-Independent Surface Chemistry and Nanodepot for Nitric Oxide. Angewandte Chemie International Edition, 2013, 52, 9187-9191. (2012 IF=13.734 Q1 4.38%, 2022 IF=16.6 Q1 7.0%) – 2013.08.26 (Online: 2013.07.10)

-Highlighted in BRIC.org

  -Representative Research Article 4

5. Juhee Park, Kaushik Singha, Sejin Son, Jihoon Kim, Ran Namgung, Chae-Ok Yun, Won Jong Kim*, A Review of RGD-Functionalized Nonviral Gene Delivery Vectors for Cancer Therapy. Cancer Gene Therapy, 2012, 19, 741-748. (2011 IF=2.802 Q2 33.23%, 2022 IF=6.4 Q1 12.5%) – 2012.11.01 (Online: 2012.09.28) 

 

4. Sejin Son, Ran Namgung, Jihoon Kim, Kaushik Singha, Won Jong Kim*, Bioreducible Polymers for Gene Silencing and Delivery. Accounts of Chemical Research, 2012, 45, 1100-1112. (2010 IF=21.840 Q1 1.7%, 2022 IF=18.3 Q1 4.8%) – 2012. 07.17 (Online: 2011.11.30)

-Highlighted in BRIC.org

 

3. Jihoon Kim (1st author), Yanggy Lee, Kaushik Singha, Hyun Woo Kim, Jae Ho Shin, Seongbong Jo, Dong-Keun Han, Won Jong Kim*, NONOates-Polyethylenimine Hydrogel for Controlled Nitric Oxide Release and Cell Proliferation Modulation. Bioconjugate Chemistry, 2011, 22, 1031-1038. (2009 IF=4.350 Q1 11.40%, 2022 IF=4.7 Q1 14.4%) – 2011.06.15 (Online: 2011.04.29)

 

2. Jihoon Kim (1st author), Sung Wan Kim, Won Jong Kim*, PEI-g-PEG-RGD/siRNA Polyplex-Mediated Silencing of VEGF Receptor and its Potential as an Anti-Angiogenic Tumor Therapeutic Strategy. Oligonucleotides (Currently, Nucleic Acid Therapeutics), 2011, 21, 101-107. (2009 IF=2.507 Q2 37.83%, 2022 Nucleic Acid Therapeutics IF=4.0 Q2 41.6%) – 2011.04.18 (Online: 2011.03.04)

 

1. Ran Namgung, Jihoon Kim, Kaushik Singha, Chun Ho Kim, Won Jong Kim*, Synergistic Effect of Low Cytotoxic Linear Polyethylenimine and Multiarm Polyethylene Glycol: Study of Physicochemical Properties and In Vitro GeneTransfection. Molecular Pharmaceutics, 2009, 6, 1826-1835. (2008 IF=4.565 Q1 10.83%, 2022 IF=4.9 Q1 22.2%) – 2009.12.07 (Online: 2009.09.30) 

bottom of page